Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2010, Article ID 928030, 5 pages
http://dx.doi.org/10.1155/2010/928030
Review Article

Cytokines and Other Mediators in Alopecia Areata

Andreas Sygros Hospital, University of Athens Medical School, 5 Ionos Dragoumi Street, 16121 Athens, Greece

Received 28 November 2009; Revised 28 January 2010; Accepted 28 January 2010

Academic Editor: Fulvio D'Acquisto

Copyright © 2010 Stamatis Gregoriou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. H. Safavi, S. A. Muller, V. J. Suman, A. N. Moshell, and L. J. Melton III, “Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989,” Mayo Clinic Proceedings, vol. 70, no. 7, pp. 628–633, 1995. View at Google Scholar · View at Scopus
  2. S. A. Muller and R. K. Winkelmann, “Alopecia areata: an evaluation of 736 patients,” Archives of Dermatology, vol. 88, pp. 290–297, 1963. View at Google Scholar
  3. M. Sato-Kawamura, S. Aiba, and H. Tagami, “Strong expression of CD40, CD54 and HLA-DR antigen and lack of evidence for direct cellular cytotoxicity are unique immunohistopathological features in alopecia areata,” Archives of Dermatological Research, vol. 294, no. 12, pp. 536–543, 2003. View at Google Scholar · View at Scopus
  4. E. Arca, U. Muşabak, A. Akar, A. H. Erbil, and H. B. Taştan, “Interferon-gamma in alopecia areata,” European Journal of Dermatology, vol. 14, no. 1, pp. 33–36, 2004. View at Google Scholar · View at Scopus
  5. M. J. Deeths, B. T. Endrizzi, M. L. Irvin, L. P. Steiner, M. E. Ericson, and M. K. Hordinsky, “Phenotypic analysis of T-cells in extensive alopecia areata scalp suggests partial tolerance,” Journal of Investigative Dermatology, vol. 126, no. 2, pp. 366–373, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. Y. Kuwano, M. Fujimoto, R. Watanabe et al., “Serum chemokine profiles in patients with alopecia areata,” British Journal of Dermatology, vol. 157, no. 3, pp. 466–473, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. S. Benoit, A. Toksoy, M. Goebeler, and R. Gilitzer, “Selective expression of chemokine induced by Interferon-γ in alopecia areata,” Journal of Investigative Dermatology, vol. 102, p. 556, 1994. View at Google Scholar
  8. R. Hoffmann, E. Wenzel, A. Huth et al., “Cytokine mRNA levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone,” Journal of Investigative Dermatology, vol. 103, no. 4, pp. 530–533, 1994. View at Google Scholar
  9. R. W. Groves, I. R. Williams, S. Sarkar, K. Nakamura, and T. S. Kupper, “Analysis of epidermal IL-1 family members in vivo using transgenic mouse models,” Journal of Investigative Dermatology, vol. 102, p. 556, 1994. View at Google Scholar
  10. R. Hoffmann, “The potential role of cytokines and T cells in alopecia areata,” Journal of Investigative Dermatology Symposium Proceedings, vol. 4, no. 3, pp. 235–238, 1999. View at Google Scholar · View at Scopus
  11. J. K. Tarlow, F. E. Clay, M. J. Cork et al., “Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene,” Journal of Investigative Dermatology, vol. 103, no. 3, pp. 387–390, 1994. View at Google Scholar · View at Scopus
  12. M. P. Philpott, D. A. Sanders, J. Bowen, and T. Kealey, “Effects of interleukins, colony-stimulating factor and tumour necrosis factor on human hair follicle growth in vitro: a possible role for interleukin-1 and tumour necrosis factor-α in alopecia areata,” British Journal of Dermatology, vol. 135, no. 6, pp. 942–948, 1996. View at Google Scholar · View at Scopus
  13. R. T. Ahini, F. S. di Giovine, and A. J. G. McDonagh, “Interleukin 1 composite genotypes as determinants for subtypes of alopecia areata,” Journal of Investigative Dermatology Symposium Proceedings, vol. 4, no. 3, p. 53, 1999. View at Google Scholar
  14. G. M. P. Galbraith, Y. Palesch, E. A. Gore, and J. P. Pandey, “Contribution of interleukin 1β and KM loci to alopecia areata,” Human Heredity, vol. 49, no. 2, pp. 85–89, 1999. View at Google Scholar · View at Scopus
  15. F. Pociot, J. Mølvig, L. Wogensen, H. Worsaae, and J. Nerup, “A TaqI polymorphism in the human interleukin-1β (IL-1β) gene correlates with IL-1β secretion in vitro,” European Journal of Clinical Investigation, vol. 22, no. 6, pp. 396–402, 1992. View at Google Scholar · View at Scopus
  16. Y. Teraki, K. Imanishi, and T. Shiohara, “Cytokines in alopecia areata: contrasting cytokine profiles in localized form and extensive form (alopecia universalis),” Acta Dermato-Venereologica, vol. 76, no. 6, pp. 421–423, 1996. View at Google Scholar · View at Scopus
  17. C. Bodemer, M. Peuchmaur, S. Fraitaig, L. Chatenoud, N. Brousse, and Y. De Prost, “Role of cytotoxic T cells in chronic alopecia areata,” Journal of Investigative Dermatology, vol. 114, no. 1, pp. 112–116, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. R. Hoffmann, E. Wenzel, A. Huth et al., “Growth factor mRNA levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone,” Acta Dermato-Venereologica, vol. 76, no. 1, pp. 17–20, 1996. View at Google Scholar · View at Scopus
  19. J. Ansel, P. Perry, J. Brown et al., “Cytokine modulation of keratinocyte cytokines,” Journal of Investigative Dermatology, vol. 94, no. 6, supplement, pp. 101S–107S, 1990. View at Google Scholar
  20. F. W. Symington, “Lymphotoxin, tumor necrosis factor, and gamma interferon are cytostatic for normal human keratinocytes,” Journal of Investigative Dermatology, vol. 92, no. 6, pp. 798–805, 1989. View at Google Scholar · View at Scopus
  21. H. S. Kim, D. H. Cho, H. J. Kim, J. Y. Lee, B. K. Cho, and H. J. Park, “Immunoreactivity of corticotropin-releasing hormone, adrenocorticotropic hormone and α-melanocyte-stimulating hormone in alopecia areata,” Experimental Dermatology, vol. 15, no. 7, pp. 515–522, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. Y. Kuwano, M. Fujimoto, R. Watanabe et al., “Serum BAFF and APRIL levels in patients with alopecia areata,” Journal of Dermatological Science, vol. 50, no. 3, pp. 236–239, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. F. Mackay, P. Schneider, P. Rennert, and J. Browning, “BAFF and APRIL: a tutorial on B cell survival,” Annual Review of Immunology, vol. 21, pp. 231–264, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. F. Mackay and H. Leung, “The role of the BAFF/APRIL system on T cell function,” Seminars in Immunology, vol. 18, no. 5, pp. 284–289, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. R. Paus, N. Ito, M. Takigawa, and T. Ito, “The hair follicle and immune privilege,” Journal of Investigative Dermatology Symposium Proceedings, vol. 8, no. 2, pp. 188–194, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. T. Christoph, S. Müller-Röver, H. Audring et al., “The human hair follicle immune system: cellular composition and immune privilege,” British Journal of Dermatology, vol. 142, no. 5, pp. 862–873, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Gilhar, Y. Ullmann, T. Berkutzki, B. Assy, and R. S. Kalish, “Autoimmune hair loss (alopecia areata)transferred by T lymphocytes to human scalp explants on SCID mice,” Journal of Clinical Investigation, vol. 101, no. 1, pp. 62–67, 1998. View at Google Scholar · View at Scopus
  28. A. J. G. McDonagh, J. A. Snowden, C. Stierle, K. Elliott, and A. G. Messenger, “HLA and ICAM-1 expression in alopecia areata in vivo and in vitro: the role of cytokines,” British Journal of Dermatology, vol. 129, no. 3, pp. 250–256, 1993. View at Google Scholar · View at Scopus
  29. M. Zöller, K. J. McElwee, M. Vitacolonna, and R. Hoffmann, “Apoptosis resistance in peripheral blood lymphocytes of alopecia areata patients,” Journal of Autoimmunity, vol. 23, no. 3, pp. 241–256, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. B. R. Bloom and B. Bennett, “Mechanism of a reaction in vitro associated with delayed-type hypersensitivity,” Science, vol. 153, no. 3731, pp. 80–82, 1966. View at Google Scholar · View at Scopus
  31. T. Shimizu, Y. Mizue, R. Abe, H. Watanabe, and H. Shimizu, “Increased macrophage migration inhibitory factor (MIF) in the sera of patients with extensive alopecia areata,” Journal of Investigative Dermatology, vol. 118, no. 3, pp. 555–557, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. T. Shimizu, N. Hizawa, A. Honda et al., “Promoter region polymorphism of macrophage migration inhibitory factor is string risk factor for young onset of extensive alopecia areata,” Genes and Immunity, vol. 6, no. 4, pp. 285–289, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. S. Kobayashi, J. Nishihira, S. Watanabe, and S. Todo, “Prevention of lethal acute hepatic failure by antimacrophage migration inhibitory factor antibody in mice treated with bacille Calmette-Guerin and lipopolysaccharide,” Hepatology, vol. 29, no. 6, pp. 1752–1759, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. X. Zhang, M. Yu, W. Yu, J. Weinberg, J. Shapiro, and K. J. McElwee, “Development of alopecia areata is associated with higher central and peripheral hypothalamic-pituitary-adrenal tone in the skin graft induced C3H/HeJ mouse model,” Journal of Investigative Dermatology, vol. 129, no. 6, pp. 1527–1538, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. P. Gupta, P. Freyschmidt-Paul, M. Vitacolonna et al., “A chronic contact eczema impedes migration of antigen-presenting cells in alopecia areata,” Journal of Investigative Dermatology, vol. 126, no. 7, pp. 1559–1573, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. R. Hoffmann, E. Wenzel, A. Huth et al., “Cytokine mRNA levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone,” Journal of Investigative Dermatology, vol. 103, no. 4, pp. 530–533, 1994. View at Google Scholar · View at Scopus
  37. R. Happle, P. van der Steen, and C. Perret, “The Renbok phenomenon: an inverse Kobner reaction observed in alopecia areata,” European Journal of Dermatology, vol. 1, pp. 228–230, 1991. View at Google Scholar
  38. V. Herbst, M. Zöller, S. Kissling, E. Wenzel, N. Stutz, and P. Freyschmidt-Paul, “Diphenylcyclopropenone treatment of alopecia areata induces apoptosis of perifollicular lymphocytes,” European Journal of Dermatology, vol. 16, no. 5, pp. 537–542, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Pan and N. A. Rao, “Alopecia areata during etanercept therapy,” Ocular Immunology and Inflammation, vol. 17, no. 2, pp. 127–129, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. W. Posten and J. Swan, “Recurrence of alopecia areata in a patient receiving etanercept injections,” Archives of Dermatology, vol. 141, no. 6, pp. 759–760, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. P. P. Sfikakis, A. Iliopoulos, A. Elezoglou, C. Kittas, and A. Stratigos, “Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction,” Arthritis and Rheumatism, vol. 52, no. 8, pp. 2513–2518, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus